U.S. Rep. and Energy and Commerce Chairman Frank Pallone Jr., D-6th District, and Kentucky U.S. Rep. Brett Guthrie, R-2nd District, on Monday introduced House Resolution 4866, the National Centers of ...

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Continuous Manufacturing Market by Product, Application and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has been added ...

The pharmaceutical industry has been slow to adopt a business practice that is faster, safer, and more efficient than its current way of operating; that the FDA has been encouraging the industry to ...

Continuous pharmaceutical manufacturing represents a significant shift from traditional batch processing, integrating continuous flow methods, advanced process analytical technology (PAT) and ...

Transform the production of oral solid dosage forms in the pharmaceutical industry with L.B. Bohle. L.B. Bohle supports companies with their machines and processes in adopting Continuous Manufacturing ...

Shanghai Pharmaceuticals has enlisted Syntegon Technology to build a laboratory for continuous manufacturing technology in China. Financial details of the deal weren’t disclosed, nor was the size of ...

This workshop will discussed the business and regulatory concerns associated with adopting continuous manufacturing techniques to produce biologics, such as enzymes, monoclonal antibodies, and ...

Dublin, May 21, 2020 (GLOBE NEWSWIRE) -- The "Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Application; End User and Geography" ...

RICHMOND, Va.--(BUSINESS WIRE)--Phlow Corp., a public benefit essential medicines solutions provider, and the United States Pharmacopeia (USP) today announced a strategic alliance to develop a new ...

The CHIPS and Science Act will allow for new investments in manufacturing research. U.S. Rep. Abigail Spanberger of Virginia is calling for increased investments to strengthen continuous prescription ...

Abigail Spanberger is backing two bipartisan bills to strengthen the capacity and security of the U.S. pharmaceutical supply chain amid fears of drug shortages as a result of the COVID-19 pandemic.